CNPR Clinical Trials 2 — Questions and Answers
Question 1: Which regulatory document must be reviewed and signed by each participant before enrolling in a clinical trial?
- Protocol synopsis
- Informed consent form (Correct answer)
- Investigator brochure
- Case report form
Correct answer: Informed consent form
The informed consent form must be reviewed, understood, and signed by each participant before enrollment to protect patient autonomy.
Question 2: What is the primary purpose of a placebo control group in a clinical trial?
- To reduce trial costs
- To provide a baseline for comparing the investigational drug's effects (Correct answer)
- To satisfy FDA requirements for trial length
- To ensure all participants receive some treatment
Correct answer: To provide a baseline for comparing the investigational drug's effects
A placebo control group provides a baseline comparator so researchers can isolate the true pharmacological effect of the investigational drug.
Question 3: What does the term 'double-blind' mean in the context of a clinical trial?
- Neither the participant nor the investigator knows who receives active drug or placebo (Correct answer)
- Only the sponsor is blinded to treatment assignments
- Two independent review boards assess the data
- The trial is conducted at two separate sites simultaneously
Correct answer: Neither the participant nor the investigator knows who receives active drug or placebo
Double-blind means both the participant and the investigator are unaware of treatment assignments, reducing bias in assessment and reporting.
Question 4: In clinical trial terminology, what is an 'endpoint'?
- The date a trial is scheduled to conclude
- A measurable outcome used to evaluate the drug's effect (Correct answer)
- The final dose level tested in Phase I
- The geographic boundary for participant recruitment
Correct answer: A measurable outcome used to evaluate the drug's effect
An endpoint is a predefined, measurable outcome such as tumor reduction or blood pressure change used to evaluate whether the drug achieves its intended effect.
Question 5: Which type of clinical trial design randomly assigns participants to treatment groups?
- Observational study
- Cohort study
- Randomized controlled trial (Correct answer)
- Case-control study
Correct answer: Randomized controlled trial
A randomized controlled trial (RCT) uses random assignment to treatment groups, minimizing selection bias and allowing causal conclusions.
Question 6: What is the role of a Data Safety Monitoring Board (DSMB) in a clinical trial?
- To recruit participants for the trial
- To independently review accumulating data and recommend trial continuation or stoppage (Correct answer)
- To approve the trial protocol before it begins
- To market the drug after trial completion
Correct answer: To independently review accumulating data and recommend trial continuation or stoppage
A DSMB independently reviews unblinded accumulating safety and efficacy data and recommends whether a trial should continue, be modified, or be stopped.
Question 7: Which document provides investigators with comprehensive information about an investigational drug's preclinical and clinical data?
- Case report form
- Informed consent form
- Investigator brochure (Correct answer)
- Study protocol
Correct answer: Investigator brochure
The investigator brochure compiles all preclinical and clinical data about the investigational drug to help investigators understand its risks and rational use.
CNPR Clinical Trials 2
Which regulatory document must be reviewed and signed by each participant before enrolling in a clinical trial?